SCHEMBL4741136

SCHEMBL4741136

COC(=O)Cc1ccc(CCO)o1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 4/20 0.56
CYP4A11 Q02928 4/20 0.56
HSP90AB1 P08238 1/20 0.42
HTT P42858 2/20 0.40
ALDH1A1 P00352 7/20 0.39
KDM4E B2RXH2 5/20 0.39
GAA P10253 2/20 0.39
GLA P06280 2/20 0.39
GFER P55789 1/20 0.39
HDAC1 Q13547 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HPGD P15428 3/20 0.38
NPSR1 Q6W5P4 1/20 0.38
NPC1 O15118 1/20 0.37
TP53 P04637 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
KMT2A Q03164 3/20 0.35
MAPT P10636 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17581887 0.89 HSP90AB1 (0.50) CYP4F2CYP4A11HSP90AB1HTTALDH1A1
SCHEMBL17581889 0.81 HSP90AB1 (0.44) CYP4F2CYP4A11HSP90AB1HTTALDH1A1
SCHEMBL10174351 0.78 ALOX5 (0.46) CYP4F2CYP4A11HSP90AB1HTTALDH1A1
SCHEMBL15522967 0.78 CES1 (0.47) CYP4F2CYP4A11ALDH1A1KDM4EGAA
SCHEMBL17077689 0.77 ALDH1A1 (0.55) CYP4F2CYP4A11HSP90AB1HTTALDH1A1
SCHEMBL17537987 0.77 ALDH1A1 (0.48) HTTALDH1A1KDM4EGAAHDAC1
SCHEMBL23395635 0.76 NPC1 (0.55) CYP4F2CYP4A11HSP90AB1HTTALDH1A1
SCHEMBL28151481 0.76 HSP90AB1 (0.43) CYP4F2CYP4A11HSP90AB1HTTALDH1A1
SCHEMBL28980172 0.76 ALDH1A1 (0.47) CYP4F2CYP4A11HSP90AB1HTTALDH1A1
SCHEMBL4741404 0.76 CYP4F2 (0.36) CYP4F2CYP4A11HSP90AB1HTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008149110-A1 BICYCLOR [2.2.1] HEPT-7-YLAMINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASES AND CONDITIONS IN WHICH M3 MUSCARINIC RECEPTOR ACTIVITY AND BETA-ADRENERGIC ACTIVITY ARE IMPLICATED ARGENTA DISCOVERY LIMITED (GB) 2008-12-11 WO disclosed
WO-2008096127-A2 BICYCLO[2.2.1]HEPT-7-YLAMINE DERIVATIVES AND THEIR USE AS M3 MUSCARINIC RECEPTOR MODULATORS ARGENTA DISCOVERY LTD (GB) 2008-08-14 WO disclosed